| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |